Literature DB >> 30422821

Rescue of recurrent deep intronic mutation underlying cell type-dependent quantitative NEMO deficiency.

Bertrand Boisson1,2,3, Yoshitaka Honda4, Masahiko Ajiro5,6, Jacinta Bustamante1,2,3,7, Matthieu Bendavid1, Andrew R Gennery8, Yuri Kawasaki9, Jose Ichishima9, Mitsujiro Osawa9, Hiroshi Nihira4, Takeshi Shiba4, Takayuki Tanaka4, Maya Chrabieh2,3, Benedetta Bigio1, Hong Hur10, Yuval Itan1,11,12, Yupu Liang10, Satoshi Okada13, Kazushi Izawa4, Ryuta Nishikomori4, Osamu Ohara14,15, Toshio Heike4,16, Laurent Abel1,2,3, Anne Puel1,2,3, Megumu K Saito9, Jean-Laurent Casanova1,2,3,17,18, Masatoshi Hagiwara5,6, Takahiro Yasumi4.   

Abstract

X-linked dominant incontinentia pigmenti (IP) and X-linked recessive anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) are caused by loss-of-function and hypomorphic IKBKG (also known as NEMO) mutations, respectively. We describe a European mother with mild IP and a Japanese mother without IP, whose 3 boys with EDA-ID died from ID. We identify the same private variant in an intron of IKBKG, IVS4+866 C>T, which was inherited from and occurred de novo in the European mother and Japanese mother, respectively. This mutation creates a new splicing donor site, giving rise to a 44-nucleotide pseudoexon (PE) generating a frameshift. Its leakiness accounts for NF-κB activation being impaired but not abolished in the boys' cells. However, aberrant splicing rates differ between cell types, with WT NEMO mRNA and protein levels ranging from barely detectable in leukocytes to residual amounts in induced pluripotent stem cell-derived (iPSC-derived) macrophages, and higher levels in fibroblasts and iPSC-derived neuronal precursor cells. Finally, SRSF6 binds to the PE, facilitating its inclusion. Moreover, SRSF6 knockdown or CLK inhibition restores WT NEMO expression and function in mutant cells. A recurrent deep intronic splicing mutation in IKBKG underlies a purely quantitative NEMO defect in males that is most severe in leukocytes and can be rescued by the inhibition of SRSF6 or CLK.

Entities:  

Keywords:  Genetics; Infectious disease; Molecular diagnosis; NF-kappaB

Mesh:

Substances:

Year:  2018        PMID: 30422821      PMCID: PMC6355244          DOI: 10.1172/JCI124011

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  89 in total

1.  Molecular characterization and gene content of breakpoint boundaries in patients with neurofibromatosis type 1 with 17q11.2 microdeletions.

Authors:  D E Jenne; S Tinschert; H Reimann; W Lasinger; G Thiel; H Hameister; H Kehrer-Sawatzki
Journal:  Am J Hum Genet       Date:  2001-07-20       Impact factor: 11.025

2.  A nucleotide change in IVS 2 of a beta-thalassemia gene leads to a cryptic splice not at the site of the mutation.

Authors:  C Dobkin; A Bank
Journal:  Prog Clin Biol Res       Date:  1983

3.  Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia.

Authors:  A Jain; C A Ma; S Liu; M Brown; J Cohen; W Strober
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

4.  Microdeletion/duplication at the Xq28 IP locus causes a de novo IKBKG/NEMO/IKKgamma exon4_10 deletion in families with Incontinentia Pigmenti.

Authors:  Francesca Fusco; Mariateresa Paciolla; Alessandra Pescatore; Maria Brigida Lioi; Carmen Ayuso; Francesca Faravelli; Mattia Gentile; Marcella Zollino; Michele D'Urso; Maria Giuseppina Miano; Matilde Valeria Ursini
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

5.  Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia.

Authors:  Jordan S Orange; Ofer Levy; Scott R Brodeur; Konrad Krzewski; Rene M Roy; Julie E Niemela; Thomas A Fleisher; Francisco A Bonilla; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2004-09       Impact factor: 10.793

6.  ESEfinder: A web resource to identify exonic splicing enhancers.

Authors:  Luca Cartegni; Jinhua Wang; Zhengwei Zhu; Michael Q Zhang; Adrian R Krainer
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

7.  A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency.

Authors:  Gilles Courtois; Asma Smahi; Janine Reichenbach; Rainer Döffinger; Caterina Cancrini; Marion Bonnet; Anne Puel; Christine Chable-Bessia; Shoji Yamaoka; Jacqueline Feinberg; Sophie Dupuis-Girod; Christine Bodemer; Susanna Livadiotti; Francesco Novelli; Paolo Rossi; Alain Fischer; Alain Israël; Arnold Munnich; Françoise Le Deist; Jean-Laurent Casanova
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

8.  A novel PCR approach for prenatal detection of the common NEMO rearrangement in incontinentia pigmenti.

Authors:  Julie Steffann; Valérie Raclin; Asmae Smahi; Hayley Woffendin; Arnold Munnich; Sue J Kenwrick; Anne-Gaelle Grebille; Alexandra Benachi; Yves Dumez; Jean-Paul Bonnefont; Smaïl Hadj-Rabia
Journal:  Prenat Diagn       Date:  2004-05       Impact factor: 3.050

9.  DNA polymerase-α regulates the activation of type I interferons through cytosolic RNA:DNA synthesis.

Authors:  Petro Starokadomskyy; Terry Gemelli; Jonathan J Rios; Chao Xing; Richard C Wang; Haiying Li; Vladislav Pokatayev; Igor Dozmorov; Shaheen Khan; Naoteru Miyata; Guadalupe Fraile; Prithvi Raj; Zhe Xu; Zigang Xu; Lin Ma; Zhimiao Lin; Huijun Wang; Yong Yang; Dan Ben-Amitai; Naama Orenstein; Huda Mussaffi; Eulalia Baselga; Gianluca Tadini; Eyal Grunebaum; Adrijan Sarajlija; Konrad Krzewski; Edward K Wakeland; Nan Yan; Maria Teresa de la Morena; Andrew R Zinn; Ezra Burstein
Journal:  Nat Immunol       Date:  2016-03-28       Impact factor: 25.606

10.  Deciphering targeting rules of splicing modulator compounds: case of TG003.

Authors:  Maki Sakuma; Kei Iida; Masatoshi Hagiwara
Journal:  BMC Mol Biol       Date:  2015-09-24       Impact factor: 2.946

View more
  18 in total

Review 1.  The genetic basis of pneumococcal and staphylococcal infections: inborn errors of human TLR and IL-1R immunity.

Authors:  Bertrand Boisson
Journal:  Hum Genet       Date:  2020-01-24       Impact factor: 4.132

2.  Clinical utility gene card: for incontinentia pigmenti.

Authors:  Francesca Fusco; Alessandra Pescatore; Julie Steffann; Jean-Paul Bonnefont; Judite De Oliveira; Maria Brigida Lioi; Matilde Valeria Ursini
Journal:  Eur J Hum Genet       Date:  2019-07-09       Impact factor: 4.246

3.  A deep intronic splice mutation of STAT3 underlies hyper IgE syndrome by negative dominance.

Authors:  Joëlle Khourieh; Geetha Rao; Tanwir Habib; Danielle T Avery; Alain Lefèvre-Utile; Marie-Olivia Chandesris; Aziz Belkadi; Maya Chrabieh; Hanan Alwaseem; Virginie Grandin; Françoise Sarrot-Reynauld; Agathe Sénéchal; Olivier Lortholary; Xiao-Fei Kong; Stéphanie Boisson-Dupuis; Capucine Picard; Anne Puel; Vivien Béziat; Qian Zhang; Laurent Abel; Henrik Molina; Nico Marr; Stuart G Tangye; Jean-Laurent Casanova; Bertrand Boisson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-25       Impact factor: 11.205

Review 4.  An appraisal of the Wilson & Jungner criteria in the context of genomic-based newborn screening for inborn errors of immunity.

Authors:  Jovanka R King; Luigi D Notarangelo; Lennart Hammarström
Journal:  J Allergy Clin Immunol       Date:  2021-02       Impact factor: 10.793

Review 5.  Regulatory genome variants in human susceptibility to infection.

Authors:  Amalio Telenti; Julia di Iulio
Journal:  Hum Genet       Date:  2019-12-05       Impact factor: 4.132

Review 6.  Induced Pluripotent Stem Cell-Derived Monocytes/Macrophages in Autoinflammatory Diseases.

Authors:  Takayuki Tanaka; Takeshi Shiba; Yoshitaka Honda; Kazushi Izawa; Takahiro Yasumi; Megumu K Saito; Ryuta Nishikomori
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

7.  Hyper-IgE Syndrome due to an Elusive Novel Intronic Homozygous Variant in DOCK8.

Authors:  Paul E Gray; Bethany A Pillay; Stuart G Tangye; Jin Yan Yap; William A Figgett; John Reeves; Sarah K Kummerfeld; Jennifer Stoddard; Gulbu Uzel; Huie Jing; Helen C Su; Dianne E Campbell; Anna Sullivan; Leslie Burnett; Jane Peake; Cindy S Ma
Journal:  J Clin Immunol       Date:  2021-10-17       Impact factor: 8.542

8.  EDA-ID: a Severe Clinical Presentation Associated with a New IKBKG Mutation.

Authors:  Antony Ceraulo; Marie Ouachée-Chardin; Coline Bret Puvilland; Bertrand Boisson; Mathieu Fusaro; Jacinta Bustamante; Yves Bertrand
Journal:  J Clin Immunol       Date:  2021-02-17       Impact factor: 8.542

Review 9.  Lethal Infectious Diseases as Inborn Errors of Immunity: Toward a Synthesis of the Germ and Genetic Theories.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Annu Rev Pathol       Date:  2020-04-14       Impact factor: 23.472

10.  Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance.

Authors:  Joëlle Khourieh; Peng Zhang; Franck Rapaport; Qian Zhang; Anne Puel; Vivien Béziat; Jean-Laurent Casanova; Bertrand Boisson; Takaki Asano; András N Spaan; Juan Li; Wei-Te Lei; Simon J Pelham; David Hum; Maya Chrabieh; Ji Eun Han; Antoine Guérin; Joseph Mackie; Sudhir Gupta; Biman Saikia; Jamila E I Baghdadi; Ilham Fadil; Aziz Bousfiha; Tanwir Habib; Nico Marr; Luckshman Ganeshanandan; Jane Peake; Luke Droney; Andrew Williams; Fatih Celmeli; Nevin Hatipoglu; Tayfun Ozcelik; Capucine Picard; Laurent Abel; Stuart G Tangye; Stéphanie Boisson-Dupuis
Journal:  J Exp Med       Date:  2021-06-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.